Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and ...

Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo ...

Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

The world’s largest drugmaker, Eli Lilly & Co., just notched another milestone: it’s the first health-care company to cross ...

Eli Lilly hit a $1 trillion valuation, driven by demand for Zepbound and Mounjaro. The first health-care firm ever to join ...

Eli Lilly’s stock reached an all-time high of 1057.42 USD, marking a significant milestone for the pharmaceutical giant with a market capitalization now exceeding $940 billion. Over the past year, the ...

The drugmaker has joined an exclusive club primarily populated by technology giants, marking a significant achievement for the healthcare sector. Eli Lilly’s stock has surged more than 35% this year, ...

Apple became the first $1 trillion company on U.S. public markets in 2018. Six of the eight companies to follow in Apple’s ...

US stocks turned higher Friday after a week of turbulence amid rising optimism for a December interest-rate cut, while bitcoin kept tumbling as AI worries continued to weigh on investors. While stocks ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...